P53 binding protein-related protein in cardiomyopathy

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S455000, C435S252300, C435S320100, C536S023100

Reexamination Certificate

active

07033793

ABSTRACT:
The present invention is directed to a mouse model of dilated cardiomyopathy in which animals are deficient in the expression of a gene encoding a p53 binding protein-related protein (PRP). The invention also encompasses the mouse PRP gene and protein themselves as well as counterparts found in the human. The various genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy.

REFERENCES:
patent: WO 00/32628 (2000-06-01), None
White, et al., “Prion Protein-Deficient Neurons Reveal Lower Glutathione Reductase Activity and Increased Susceptibility to Hydrogen Peroxide Toxicity,”Am. J. Pathol. 155:1723-1730 (1999).
Abstract of AF1 above.
University of Chicago Hospitals Jun. 1998 News Release, “Gene Altered Mice Boost Studies of Cardiomyopathy,” www.uchospitals.edu
ews/1998/19980601-ide-mouse.html.
Bradley, et al., “Embryo-Derived Stem Cells: A Tool for Elucidating the Development Genetics of the Mouse,”Current Topics in Dev. Biol. 20:357-371 (1986).
Capecchi, “The New Mouse Genetics: Altering the Genome by Gene Targeting,”Trends in Genetics 5:70-77 (1989).
Doetschman, et al., “Targetted Correction of a Mutant HPRT Gene in Mouse Embryonic Stem Cells,”Nature 330:576-578 (1987).
Mansour, et al., “Disruption of the Proto-Oncogene int-2 in Mouse Embryo-Derived Stem Cells: A General Strategy for T argeting Mutations to Non-Selectable Genes,”Nature 336:348-352 (1988).
Thomas, et al., “Site-Directed Mutagenesis by Gene Targeting in Mouse Embryo-Derived Stem Cells,”Cell 51:503-512 (1987).
Yang, et al., “Indentification of a Novel Inhibitor of Nuclear Factor-kB, RelA-Associated Inhibitor,”J. Biol. Chem. 274:15662-15670 (1999).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

P53 binding protein-related protein in cardiomyopathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with P53 binding protein-related protein in cardiomyopathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P53 binding protein-related protein in cardiomyopathy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3620921

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.